EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment.
*hb1004*
HOUSE BILL 1004
J1 5lr2242
CF SB 748
By: Delegate Martinez Delegates Martinez, Alston, Bagnall, Bhandari, Cullison,
Guzzone, Hill, Hutchinson, S. Johnson, Kaiser, Kerr, Kipke, Lopez,
Pena–Melnyk, Reilly, Rosenberg, Ross, Taveras, White Holland, Woods, and
Woorman
Introduced and read first time: January 31, 2025
Assigned to: Health and Government Operations
Committee Report: Favorable with amendments
House action: Adopted
Read second time: March 6, 2025
CHAPTER ______
AN ACT concerning 1
Public Health – Alzheimer’s Disease and Related Dementias – Information on 2
Prevalence and Treatment 3
FOR the purpose of requiring the Maryland Department of Health, in partnership with 4
certain entities, to incorporate information regarding treatments approved by the 5
Food and Drug Administration for Alzheimer’s disease and related dementias and to 6
increase understanding and awareness of treatment of Alzheimer’s disease and 7
related dementias into relevant public health outreach programs administered by 8
the Department; requiring the Department to establish and maintain a website that 9
includes certain information on the prevalence and hospitalization rate of 10
Alzheimer’s disease and related dementias; and generally related to Alzheimer’s 11
disease and related dementias. 12
BY repealing and reenacting, with amendments, 13
Article – Health – General 14
Section 18–110 15
Annotated Code of Maryland 16
(2023 Replacement Volume and 2024 Supplement) 17
BY adding to 18
Article – Health – General 19
Section 18–111 20 2 HOUSE BILL 1004
Annotated Code of Maryland 1
(2023 Replacement Volume and 2024 Supplement) 2
SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 3
That the Laws of Maryland read as follows: 4
Article – Health – General 5
18–110. 6
The Department, in partnership with the Department of Aging, the Virginia I. Jones 7
Alzheimer’s Disease and Related Disorders DEMENTIAS Council, and the Greater 8
Maryland Chapter of the Alzheimer’s Association, shall incorporate information into 9
relevant public health outreach programs administered by the Department to: 10
(1) Educate health care providers regarding: 11
(i) The importance of early detection and timely diagnosis of 12
cognitive impairment; 13
(ii) Validated assessment tools for the detection and diagnosis of 14
cognitive impairment; 15
(iii) The value of a Medicare annual wellness visit or other annual 16
physical for an individual at least 65 years old for cognitive health; [and] 17
(iv) The Medicare care planning billing code for individuals with 18
cognitive impairment; and 19
(V) TREATMENTS APPROVED B Y THE FOOD AND DRUG 20
ADMINISTRATION FOR ALZHEIMER’S DISEASE AND R ELATED DEMENTIAS , 21
INCLUDING RELEVANT I NFORMATION ON TREATM ENT USE AND OUTCOMES ; AND 22
(2) Increase PUBLIC understanding and awareness of: 23
(i) The early warning signs of Alzheimer’s disease and [other types 24
of dementia] RELATED DEMENTIAS ; 25
(ii) The value of early detection [and], diagnosis, AND TREATMENT 26
of Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS ; and 27
(iii) How to reduce the risk of cognitive decline, particularly among 28
individuals in Black and Latino communities who are at greater risk of developing 29
Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS ; AND 30
HOUSE BILL 1004 3
(IV) TREATMENTS APPROVED B Y THE U.S. FOOD AND DRUG 1
ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATE D DEMENTIAS AND 2
RELEVANT INFORMATION ON TREATMENT USE AND OUTCOMES, INCLUDING 3
INFORMATION RELATED TO TREATMENT OUTCOME S BASED ON BIOLOGICA L SEX. 4
18–111. 5
(A) THE DEPARTMENT , IN COLLABORATION WITH T HE STATE–DESIGNATED 6
HEALTH INFORMATION E XCHANGE, SHALL ESTABLISH AND MAINTAIN A PUBLICLY 7
ACCESSIBLE WEBSITE T HAT INCLUDES IN A DO WNLOADABLE FORMAT TH E 8
FOLLOWING INFORMATIO N: 9
(1) THE PREVALENCE OF ALZHEIMER’S DISEASE AND RELATE D 10
DEMENTIAS IN THE STATE; 11
(2) THE HOSPITALIZATION R ATE RELATED TO ALZHEIMER’S DISEASE 12
AND RELATED DEMENTIA S; AND 13
(3) TO THE EXTENT POSSIBL E, THE PREVALENCE AND 14
HOSPITALIZATION RATE OF ALZHEIMER’S DISEASE AND RELATE D DEMENTIAS 15
DISAGGREGATED BASED ON: 16
(I) AGE, INCLUDING AGE OF DIA GNOSIS; 17
(II) SEX; 18
(III) RACE; 19
(IV) ETHNICITY; AND 20
(V) NUMBER OF CASES BY CO UNTY; 21
(VI) CO–OCCURRENCE OF DOWN SYNDROME (TRISOMY–21); 22
AND 23
(VII) TYPE OF DEMENTIA . 24
(B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION 25
SHALL: 26
(1) INCLUDE THE DATA AVAI LABLE FOR THE IMMEDI ATELY 27
PRECEDING 5–YEAR PERIOD ENDING SEPTEMBER 30, 2025; AND 28
4 HOUSE BILL 1004
(2) BE UPDATED ON OR BEFO RE JANUARY 1 EACH YEAR, BEGINNING 1
IN 2027, TO INCLUDE ANY NEWLY AVAILABLE DATA . 2
SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 3
October 1, 2025. 4
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
Speaker of the House of Delegates.
________________________________________________________________________________
President of the Senate.